P659-2133 Screening compound: butyl(methyl){[5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}amine

P659-2133 Screening compound: butyl(methyl){[5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}amine
P659-2133 Screening compound: butyl(methyl){[5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}amine alternative view

Chemical Structure Depiction of ChemDiv screening compound P659-2133
butyl(methyl){[5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P659-2133

Molecular Formula

C17H29N7 (C17 H29 N7)

Compound Name

butyl(methyl){[5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}amine

IUPAC name

butyl(methyl){[5-methyl-7-(4-methylpiperazin-1-yl)-[124]triazolo[15-a]pyrimidin-2-yl]methyl}amine

SMILES

CCCCN(C)Cc1nn2c(N3CCN(C)CC3)cc(C)nc2n1

InChI

InChI=1S/C17H29N7/c1-5-6-7-22(4)13-15-19-17-18-14(2)12-16(24(17)20-15)23-10-8-21(3)9-11-23/h12H,5-11,13H2,1-4H3

InChI Key

WUHNAFUWYIPISS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27609870

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

331.46

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.667

Distribution Coefficient, logD

1.042

Water Solubility, LogSw

-1.22

Polar Surface Area

41.950

Acid Dissociation Constant (pKa)

24.50

Base Dissociation Constant (pKb)

7.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

70.60

P659-2133 in Drug Discovery

Included in Screening Libraries

CNS BBB Library (22607 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with P659-2133 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P659-2133?
Check Price and Availability of P659-2133, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P659-2133 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P659-2133
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P659-2133
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P659-2133 available by request